Study wrapper · #1112
Kisspeptin Signaling Suppresses HRasG12V-induced Tumor Growth and Metastasis by Inhibiting SP1-dependent N-cadherin Expression in NIH3T3 Cells.
Hwang HH, Cho SG Anticancer research. 2026.
DOI: 10.21873/anticanres.18291PubMed: 42527090
Editor's note
An in vitro and mouse-model study identifying a metastasis-suppressive mechanism for kisspeptin signaling in HRAS-driven cells. As mechanistic bench science it is early-stage evidence about kisspeptin biology, well upstream of any clinical inference.
Plain-language abstract
This laboratory study found that kisspeptin signaling suppressed tumor growth and metastasis in an engineered cell line by inhibiting a specific gene-expression pathway. Findings in cultured cells and mouse models are early-stage and may not translate to humans.
Related coverage
Supported
Kisspeptin-10/basal LH ratio improves differentiation of central precocious puberty and premature thelarche.
Clinica chimica acta; international journal of clinical chemistryn=——2027
Weak / none
The kisspeptin analog C6 elicits greater tachyphylaxis and transcriptional activation than kisspeptin-10 and -54.
Molecular and cellular endocrinologyn=——2026
Mixed
Kisspeptin System: A Modulator of Neuroinflammation and Behaviour in Temporal Lobe Epileptic Rats.
Molecular neurobiologyn=——2026